Toxicity and metabolism of methylnaphthalenes: Comparison with naphthalene and 1-nitronaphthalene

Toxicology

Volumn 260, Issue 1-3, 2009, Pages 16-27

  Lin, Ching Yu ^a   Wheelock, Åsa M ^a   Morin, Dexter ^a   Baldwin, R Michael ^a   Lee, Myong Gong ^a   Taff, Aysha ^a   Plopper, Charles ^a   Buckpitt, Alan ^a   Rohde, Arlean ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

Author keywords

1 Methylnaphthalene; 1 Nitronaphthalene; 2 Methylnaphthalene; Clara cells; Cytochrome P450; Dimethylnaphthalenes; Naphthalene; Nasal toxicity; Respiratory tract

Indexed keywords

1 METHYLNAPHTHALENE; 1 NITRONAPHTHALENE; 2 ISOPROPYLNAPHTHALENE; 2 METHYLNAPHTHALENE; 2,6 DIISOPROPYLNAPHTHALENE; CELL PROTEIN; CYTOCHROME P450; EPOXIDE; GLUTATHIONE; NAPHTHALENE; NAPHTHALENE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; CARCINOGENESIS; CHRONIC TOXICITY; COMPARATIVE TOXICOLOGY; CONCENTRATION RESPONSE; CYTOTOXICITY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPOXIDATION; HUMAN; LUNG TOXICITY; METABOLITE; NONHUMAN; NOSE MUCOSA; PRIMATE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVIEW; STEREOCHEMISTRY; TOXICOKINETICS; URINE LEVEL;

ANIMALS; ENVIRONMENTAL EXPOSURE; HUMANS; LUNG DISEASES; NAPHTHALENES;

ANIMALIA; MUS; PRIMATES; RATTUS; RODENTIA;

EID: 67349149647     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.03.002     Document Type: Review

References (109)

1. Abdo K., Eustis S., McDonald M., Joiken M., Adkins B., and Haseman J. Naphthalene: a respiratory tract toxicant and carcinogen for mice. Inhal. Toxicol. 4 (1992) 393-409
2. Abdo K.M., Grumbein S., Chou B.J., and Herbert R. Toxicity and carcinogenicity study in f344 rats following 2 years of whole-body exposure to naphthalene vapors. Inhal. Toxicol. 13 (2001) 931-950
3. Aislabie J., Balks M., Astori N., Stevenson G., and Symons R. Polycyclic aromatic hydrocarbons in fuel-oil contaminated soils. Antarctica Chemosphere 39 (1999) 2201-2207
4. Anon, 2005. Toxicological profile for naphthalene, 1-methylnaphthalene and 2-methylnaphthalene. Agency for Toxic Substances and Disease Registry http://www.atsdr.cdc.gov/toxprofiles/tp67.pdf.
5. Anon, 1984. Handbook on manufactured gas plant sites. Environmental Research and Technology Inc. Prepared for utility solid waste activities group, Superfund committee. Project # P-D215.
6. Bagheri H., and Creaser C.S. Determination of some two- and three-ring aromatic hydrocarbons by combined gas chromatography and fluorescence spectrometry. Analyst 113 (1988) 1175-1178
7. Baldwin R.M., Jewell W.T., Fanucchi M.V., Plopper C.G., and Buckpitt A.R. Comparison of pulmonary/nasal CYP2F expression levels in rodents and rhesus macaque. J. Pharmacol. Exp. Ther. 309 (2004) 127-136
8. Baldwin R.M., Shultz M.A., and Buckpitt A.R. Bioactivation of the pulmonary toxicants naphthalene and 1-nitronaphthalene by rat CYP2F4. J. Pharmacol. Exp. Ther. 312 (2005) 857-865
9. Bjorseth A., Bjorseth O., and Fjeldstad P.E. Polycyclic aromatic hydrocarbons in the work atmosphere. I. Determination in an aluminum reduction plant. Scand. J. Work Environ. Health 4 (1978) 212-223
10. Born S.L., Caudill D.K., Fliter L., and Purdon M.P. Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation. Drug Metab. Dispos. 30 (2002) 483-487
11. Breger R.K., Franklin R.B., and Lech J.J. Metabolism of 2-methylnaphthalene to isomeric dihydrodiols by hepatic microsomes of rat and rainbow trout. Drug Metab. Dispos. 9 (1981) 88-93
12. Breger R., Novak R., Franklin R., Rickert D., and Lech J. Further structural analysis of rat liver microsomal metabolites of 2-methylnaphthalene. Drug Metab. Dispos. 11 (1983) 319-323
13. Brusick D. Critical assessment of the genetic toxicity of naphthalene. Regul. Toxicol. Pharmacol. 51 (2008) S37-S42
14. Buckpitt A.R., Bahnson L.S., and Franklin R.B. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation. J. Pharmacol. Exp. Ther. 231 (1984) 291-300
15. Buckpitt A., Boland B., Isbell M., Morin D., Shultz M., Baldwin R., Chan K., Karlsson A., Lin C., Taff A., West J., Fanucchi M., Van Winkle L., and Plopper C. Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metab. Rev. 34 (2002) 791-820
16. Buckpitt A., Chang A., Weir A., Van Winkle L., Duan X., Philpot R.M., and Plopper C.G. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats and hamsters. Mol. Pharmacol. 47 (1995) 74-81
17. Buckpitt A.R., and Warren D.L. Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo. J. Pharmacol. Exp. Ther. 225 (1983) 8-16
18. Chapman K.R., Mannino D.M., Soriano J.B., Vermeire P.A., Buist A.S., Thun M.J., Connell C., Jemal A., Lee T.A., Miravitlles M., Aldington S., and Beasley R. Epidemiology and costs of chronic obstructive pulmonary disease. Eur. Respir. J. 27 (2006) 188-207
19. Chen K., and Dorough H. Glutathione and mercapturic acid conjugations in the metabolism of naphthalene and 1-naphthyl N-methylcarbamate (carbaryl). Drug Chem. Toxcol. 2 (1979) 331-354
20. Cho T.M., Rose R.L., and Hodgson E. In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes. Drug Metab. Dispos. 34 (2006) 176-183
21. Cruzan G., Carlson G.P., Johnson K.A., Andrews L.S., Banton M.I., Bevan C., and Cushman J.R. Styrene respiratory tract toxicity and mouse lung tumors are mediated by CYP2F-generated metabolites. Regul. Toxicol. Pharmacol. 35 (2002) 308-319
22. Ding X., and Kaminsky L.S. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 149-173
23. Dinsdale D., and Verschoyle R.D. Pulmonary toxicity of naphthalene derivatives in the rat. Arch. Toxicol. Suppl. 11 (1987) 288-291
24. Dodd, D.E., James, R.A., Gross, E.A., Miller, R.A., Piccirillo, V.J., Wong, B.A., 2008. Nasal epithelial lesions in rats following an acute inhalation exposure to naphthalene vapor at low concentrations. Toxicologist, 510 abs.
25. el Bayoumy K., Reddy B., and Hecht S.S. Identification of ring oxidized metabolites of 1-nitropyrene in the feces and urine of germfree F344 rats. Carcinogenesis 5 (1984) 1371-1373
26. Fanucchi M.V., Buckpitt A.R., Murphy M.E., and Plopper C.G. Naphthalene cytotoxicity of differentiating Clara cells in neonatal mice. Toxicol. Appl. Pharmacol. 144 (1997) 96-104
27. Fanucchi M.V., Day K.C., Clay C.C., and Plopper G.C. Increased vulnerability of neonatal rats and mice to 1-nitronaphthalene-induced pulmonary injury. Toxicol. Appl. Pharmacol. 201 (2004) 53-65
28. Farant J.P., and Ogilvie D. Investigation of the presence of amino and nitro polycyclic aromatic hydrocarbons in a Soderberg primary aluminum smelter. AIHA J. 63 (2002) 721-725
29. Franklin R., Plopper C., and Buckpitt A. Naphthalene and 2-methylnaphthalene-induced pulmonary bronchiolar epithelial cell necrosis: metabolism and relationship to toxicity. In: Gram T. (Ed). Metabolic Activation and Toxicity of Chemical Agents to Lung Tissue and Cells (1993), Pergamon Press, New York 123-144
30. Fukami T., Katoh M., Yamazaki H., Yokoi T., and Nakajima M. Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene, styrene, and toluene. Chem. Res. Toxicol. 21 (2008) 720-725
31. Gallego E., Roca F.J., Perales J.F., Guardino X., and Berenguer M.J. VOCs and PAHs emissions from creosote-treated wood in a field storage area. Sci. Total Environ. 402 (2008) 130-138
32. Ghanem A., and Shuler M.L. Combining cell culture analogue reactor designs and PBPK models to probe mechanisms of naphthalene toxicity. Biotechnol. Prog. 16 (2000) 334-345
33. Griffin K.A., Johnson C.B., Breger R.K., and Franklin R.B. Effects of inducers and inhibitors of cytochrome P-450-linked monooxygenases on the toxicity, in vitro metabolism and in vivo irreversible binding of 2-methylnaphthalene in mice. J. Pharmacol. Exp. Ther. 221 (1982) 517-524
34. Griffin K.A., Johnson C.B., Breger R.K., and Franklin R.B. Pulmonary toxicity, hepatic, and extrahepatic metabolism of 2-methylnaphthalene in mice. Toxicol. Appl. Pharmacol. 61 (1981) 185-196
35. Griffin K.A., Johnson C.B., Breger R.K., and Franklin R.B. Pulmonary toxicity of 2-methylnaphthalene: lack of a relationship between toxicity, dihydrodiol formation and irreversible binding to cellular macromolecules in DBA/2J mice. Toxicology 26 (1983) 213-230
36. Grosovsky, A.J., Sasaki, J.C., Arey, J., Eastmond, D.A., Parks, K.K., Atkinson, R., 1999. Evaluation of the potential health effects of the atmospheric reaction products of polycyclic aromatic hydrocarbons. Health Effects Institute, Research Report # 84, Boston, MA, pp. 1-29.
37. Gupta P., Harger W., and Arey J. The contribution of nitro and methylnitronaphthalenes to the vapor phase mutagenicity of ambient air samples. Atmos. Environ. 30 (1996) 3157-3166
38. Halladay J., Sauer J., and Sipes I. The metabolism and disposition of 1-nitronaphthalene in the male Sprague Dawley rat. Drug Metab. Dispos. 27 (1999) 1456-1465
39. Halpert J.R. Structural basis of selective cytochrome P450 inhibition. Ann. Rev. Pharmacol. Toxicol. 35 (1995) 29-53
40. Hampton C.V., Pierson W.R., Schuetzie D., and Harver T.M. Hydrocarbon gases emitted from vehicles on the road 2. Determination of emission rates from diesel and spark-ignition vehicles. Environ. Sci. Technol. 17 (1983) 699-708
41. Honda T., Fukada A., Kiyozumi M., and Kojima S. Identification and determination of urinary metabolites of 2-isopropylnaphthalene in rabbits. Eur. J. Drug Metab. Pharmacokinet. 12 (1987) 11-16
42. Honda T., Kiyozumi M., and Kojima S. Alkylnaphthalene. XI. Pulmonary toxicity of naphthalene, 2-methylnaphthalene, and isopropylnaphthalenes in mice. Chem. Pharm. Bull. (Tokyo) 38 (1990) 3130-3135
43. Hoke H., and Zellerhoff R. Metabolism and toxicity of diisopropylnaphthalene as compared to naphthalene and monoalkyl naphthalenes: a minireview. Toxicology 126 (1998) 1-7
44. Ikegami M., Whitsett J.A., Chroneos Z.C., Ross G.F., Reed J.A., Bachurski C.J., and Jobe A.H. IL-4 increases surfactant and regulates metabolism in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 278 (2000) L75-L80
45. Ioachimescu O.C., and Kavuru M.S. Pulmonary alveolar proteinosis. Chronic. Respir. Dis. 3 (2006) 149-159
46. Kang-Sickel J.C., Fox D.D., Nam T.G., Jayaraj K., Ball L.M., French J.E., Klapper D.G., Gold A., and Nylander-French L.A. S-arylcysteine-keratin adducts as biomarkers of human dermal exposure to aromatic hydrocarbons. Chem. Res. Toxicol. 21 (2008) 852-858
47. Kilanowicz A., Sapota A., and Darago A. Disposition and metabolism of 1,4-dimethylnaphthalene in rat. Int. J. Occup. Med. Environ. Health 13 (2000) 325-334
48. Kilanowicz A., Sapota A., and Czerski B. Disposition and metabolism of 1,6-dimethylnaphthalene in rats. Toxicol. Lett. 134 (2002) 227-235
49. Kilanowicz A., and Sapota A. Disposition and metabolism of 1,2-dimethylnaphthalene in rats. Int. J. Occup. Med. Environ. Health 11 (1998) 305-317
50. Kim D., Andersen M.E., and Nylander-French L.A. Dermal absorption and penetration of jet fuel components in humans. Toxicol. Lett. 165 (2006) 11-21
51. Kobayashi R., Okamoto R.A., Maddalena R.L., and Kado N.Y. Polycyclic aromatic hydrocarbons in edible grain: a pilot study of agricultural crops as a human exposure pathway for environmental contaminants using wheat as a model crop. Environ. Res. 107 (2008) 145-151
52. Kojima S.T., Honda M., Nakagawa M., Kiyozumi M., and Takadate A. Urinary metabolites of 2,6-diisopropylnaphthalene in rats. Drug Metab. Dispos. 10 (1982) 429-433
53. Kojima S., Honda T., and Kiyozumi M. Biliary metabolites of 2,6-diisopropylnaphthalene in rats. Bull. Environ. Contam. Toxicol. 35 (1985) 745-749
54. Korsak Z., Majcherek W., and Rydzynski K. Toxic effects of acute inhalation exposure to 1-methylnaphthalene and 2-methylnaphthalene in experimental animals. Int. J. Occup. Med. Environ. Health 11 (1998) 335-342
55. Kulka U., Schmid E., Huber R., and Bauchinger M. Analysis of the cytogenetic effect in human lymphocytes induced by metabolically activated 1- and 2-methylnaphthalene. Mutat. Res. 208 (1988) 155-158
56. Lakritz J., Chang A., Weir A., Nishio S., Hyde D., Philpot R., Buckpitt A., and Plopper C. Cellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: Bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene. J. Pharmacol. Exp. Ther. 278 (1996) 1408-1418
57. Lee M.G., Phimister A., Morin D., Buckpitt A., and Plopper C. In situ naphthalene bioactivation and nasal airflow cause region-specific injury patterns in the nasal mucosa of rats exposed to naphthalene by inhalation. J. Pharmacol. Exp. Ther. 314 (2005) 103-110
58. Lee M.G., Wheelock A.M., Boland B., and Plopper C.G. Long-term ozone exposure attenuates 1-nitronaphthalene-induced cytotoxicity in nasal mucosa. Am. J. Respir. Cell Mol. Biol. 38 (2008) 300-309
59. Li Z., Sandau C.D., Romanoff L.C., Caudill S.P., Sjodin A., Needham L.L., and Patterson Jr. D.G. Concentration and profile of 22 urinary polycyclic aromatic hydrocarbon metabolites in the US population. Environ. Res. 107 (2008) 320-331
60. Mahvi D., Bank H., and Harley R. Morphology of a naphthalene-induced bronchiolar lesion. Am. J. Pathol. 86 (1977) 559-572
61. Melancon M.J., Williams D.E., Buhler D.R., and Lech J.J. Metabolism of 2-methylnaphthalene by rat and rainbow trout hepatic microsomes and purified cytochromes P-450. Drug Metab. Dispos. 13 (1985) 542-547
62. Melancon M.J., Rickert D.E., and Lech J.J. Metabolism of 2-methylnaphthalene in the rat in vivo. I. Identification of 2-naphthoylglycine. Drug Metab. Dispos. 10 (1982) 128-133
63. Murata Y., Denda A., Maruyama H., and Konishi Y. Chronic toxicity and carcinogenicity studies of 1-methylnaphthalene in B6C3F1 mice. Fundam. Appl. Toxicol. 21 (1993) 44-51
64. Murata Y., Denda A., Maruyama H., Nakae D., Tsutsumi M., Tsujiuchi T., and Konishi Y. Chronic toxicity and carcinogenicity studies of 2-methylnaphthalene in B6C3F1 mice. Fundam. Appl. Toxicol. 36 (1997) 90-93
65. Murata Y., Emi Y., Denda A., and Konishi Y. Ultrastructural analysis of pulmonary alveolar proteinosis induced by methylnaphthalene in mice. Exp. Toxicol. Pathol. 44 (1992) 47-54
66. NIOSH: Hazard Review, 2000. Health effects of occupational exposure to asphalt. DHHS publication # 2001-110, http://www.cdc.gov/niosh/docs/2001-110/.
67. 2 concentration. Environ. Sci. Technol. 42 (2008) 9203-9209
68. O'Brien K.A., Suverkropp C., Kanekal S., Plopper C.G., and Buckpitt A.R. Tolerance to multiple doses of the pulmonary toxicant, naphthalene. Toxicol. Appl. Pharmacol. 99 (1989) 487-500
69. Paige R., Wong V., and Plopper C.G. Dose-related airway specific epithelial toxicity of 1-nitronaphthalene in rats. Toxicol. Appl. Pharmacol. 147 (1997) 224-233
70. Paige R.C., Wong V., and Plopper C.G. Long-term exposure to ozone increases acute pulmonary centriacinar injury by 1-nitronaphthalene: II. Quantitative histopathology. J. Pharmacol. Exp. Ther. 295 (2000) 942-950
71. Pakenham G., Lango J., Buonarati M., Morin D., and Buckpitt A. Urinary naphthalene mercapturates as biomarkers of exposure and stereoselectivity of naphthalene epoxidation. Drug Metab. Dispos. 30 (2002) 247-253
72. Phousongphouang P.T., and Arey J. Rate constants for the gas-phase reactions of a series of alkylnaphthalenes with the OH radical. Environ. Sci. Technol. 36 (2002) 1947-1952
73. Phousongphouang P.T., and Arey J. Rate constants for the gas-phase reactions of a series of alkylnaphthalenes with the nitrate radical. Environ. Sci. Technol. 37 (2003) 308-313
74. Plopper C.G. Pulmonary bronchiolar epithelial cytotoxicity: microanatomical considerations. In: Gram T.E. (Ed). Metabolic Activation and Toxicity of Chemical Agents to Lung Tissue and Cells (1993), Pergamon Press, New York 1-24
75. Plopper C.G., Chang A., Pang A., and Buckpitt A. Use of microdissected airways to better define metabolism and cytotoxicity in murine bronchiolar epithelium. Exp. Lung Res. 17 (1991) 181-196
76. Plopper C.G., Suverkropp C., Morin D., Nishio S., and Buckpitt A. Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. I. Histopathologic comparison of the respiratory tract of mice, rats and hamsters after parenteral administration of naphthalene. J. Pharmacol. Exp. Ther. 261 (1992) 353-363
77. Plopper C.G., Macklin J., Nishio S., Hyde D., and Buckpitt A. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. III. Morphometric comparison of changes in the epithelial populations of terminal bronchioles and lobar bronchi in mice, hamsters and rats after parenteral administration of naphthalene. Lab Invest. 67 (1992) 553-565
78. Preuss R., Angerer J., and Drexler H. Naphthalene-an environmental and occupational toxicant. Int. Arch. Occup. Environ. Health 76 (2003) 556-576
79. Quick D.J., and Shuler M.L. Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences. Biotechnol. Prog. 15 (1999) 540-555
80. Rasmussen R., Do D., Kim T., and Dearden L. Comparative cytotoxicity of naphthalene and its monomethyl- and mononitro-derivatives in the mouse lung. J. Appl. Toxicol. 6 (1986) 13-20
81. Rasmussen R.E. Metabolism and macromolecular binding of 1-nitronaphthalene in the mouse. Toxicology 41 (1986) 233-247
82. Reisen F., and Arey J. Atmospheric reactions influence seasonal PAH and nitro-PAH concentrations in the Los Angeles basin. Environ. Sci. Technol. 39 (2005) 64-73
83. Ryerse J.S., Hoffmann J.W., Mahmoud S., Nagel B.A., and deMello D.E. Immunolocalization of CC10 in Clara cells in mouse and human lung. Histochem. Cell Biol. 115 (2001) 325-332
84. Salam M.T., Lin P.C., Avol E.L., Gauderman W.J., and Gilliland F.D. Microsomal epoxide hydrolase, glutathione S-transferase P1, traffic and childhood asthma. Thorax 62 (2007) 1050-1057
85. Sauer J., Eversole R., Lehmann C., Johnson D., and Beuving L. An ultrastructural evaluation of acute 1-nitronaphthalene induced hepatic and pulmonary toxicity in the rat. Toxicol. Lett. 90 (1997) 19-27
86. Sauer J.M., Hooser S.B., and Sipes I.G. All-trans-retinol alteration of 1-nitronaphthalene-induced pulmonary and hepatic injury by modulation of associated inflammatory responses in the male Sprague-Dawley rat. Toxicol. Appl. Pharmacol. 133 (1995) 139-149
87. Schmeltz I., Tosk J., and Hoffman D. Formation and determination of naphthalenes in cigarette smoke. Anal. Chem. 48 (1976) 645-650
88. Schmelzer K.R., Wheelock A.M., Dettmer K., Morin D., and Hammock B.D. The role of inflammatory mediators in the synergistic toxicity of ozone and 1-nitronaphthalene in rat airways. Environ. Health Perspect. 114 (2006) 1354-1360
89. Shultz M.A., Morin D., Chang A.M., and Buckpitt A. Metabolic capabilities of CYP2F2 with various pulmonary toxicants and its relative abundance in mouse lung subcompartments. J. Pharmacol. Exp. Ther. 296 (2001) 510-519
90. Serabjit-Singh C., Wolf C., Philpot R., and Plopper C. Cytochrome P450: localization in rabbit lung. Science 207 (1980) 1469-1470
91. Stillwell W., Bouwsma O., Thenot J., Horning M., Griffin G., Ishikawa K., and Takaku M. Methylthio metabolites of naphthalene excreted by the rat. Res. Commun. Chem. Pathol. Pharmacol. 20 (1978) 509-530
92. Stillwell W., Horning M., Griffin G., and Tsang W. Identification of new sulfur-containing metabolites of napthalene in mouse urine. Drug Metab. Dispos. 10 (1982) 624-631
93. Teshima R., Nagamatsu K., Ikebuchi H., Kido Y., and Terao T. In vivo and in vitro metabolism of 2-methylnaphthalene in the guinea pig. Drug Metab. Dispos. 11 (1983) 152-157
94. Toriba A., Kitaoka H., Dills R.L., Mizukami S., Tanabe K., Takeuchi N., Ueno M., Kameda T., Tang N., Hayakawa K., and Simpson C.D. Identification and quantification of 1-nitropyrene metabolites in human urine as a proposed biomarker for exposure to diesel exhaust. Chem. Res. Toxicol. 20 (2007) 999-1007
95. Van Winkle L.S., Gunderson A.D., Shimizu J.A., Baker G.L., and Brown C.D. Gender differences in naphthalene metabolism and naphthalene-induced acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 282 (2002) L1122-L1134
96. Verschoyle R.D., and Dinsdale D. Protection against chemical-induced lung injury by inhibition of pulmonary cytochrome P-450. Environ. Health Perspect. 85 (1990) 95-100
97. Verschoyle R.D., Carthew P., Wolf C.R., and Dinsdale D. 1-Nitronaphthalene toxicity in rat lung and liver: effects of inhibiting and inducing cytochrome P450 activity. Toxicol. Appl. Pharmacol. 122 (1993) 208-213
98. Wang L., Atkinson R., and Arey J. Dicarbonyl products of the OH radical-initiated reactions of naphthalene and the C1- and C2-alkylnaphthalenes. Environ. Sci. Technol. 41 (2007) 2803-2810
99. Warren D.L., Brown Jr. D., and Buckpitt A. Evidence for cytochrome P450 mediated metabolism in the bronchiolar damage by naphthalene. Chem. Biol. Interact. 40 (1982) 287-303
100. Watt K.C., and Buckpitt A.R. Species differences in the regio- and stereoselectivity of 1-nitronaphthalene metabolism. Drug Metab. Dispos. 28 (2000) 376-378
101. Watt K., Morin D., Kurth M.J., Mercer R.S., Plopper C.G., and Buckpitt A. Glutathione conjugation of electrophilic metabolites of 1-nitronaphthalene in rat tracheobronchial airways and liver: identification by mass spectrometry and proton nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 12 (1999) 831-839
102. West J.A., Buckpitt A.R., and Plopper C.G. Elevated airway GSH resynthesis confers protection to Clara cells from naphthalene injury in mice made tolerant by repeated exposures. J. Pharmacol. Exp. Ther. 294 (2000) 516-523
103. West J., Pakenham G., Morin D., Fleschner C., Buckpitt A., and Plopper C. Inhaled naphthalene causes dose-dependent Clara cell toxicity in mice but not in rats. Toxicol. Appl. Pharmacol. 173 (2001) 114-119
104. West J.A., Van Winkle L.S., Morin D., Fleschner C.A., Forman H.J., and Plopper C.G. Repeated inhalation exposures to the bioactivated cytotoxicant naphthalene (NA) produce airway-specific Clara cell tolerance in mice. Toxicol. Sci. 75 (2003) 161-168
105. West J.A., Williams K.J., Toskala E., Nishio S.J., Fleschner C.A., Forman H.J., Buckpitt A.R., and Plopper C.G. Induction of tolerance to naphthalene in Clara cells is dependent on a stable phenotypic adaptation favoring maintenance of the glutathione pool. Am. J. Pathol. 160 (2002) 1115-1127
106. Wheelock A., Zhang L., Tran M.-U., Morin D., Penn S., Buckpitt A., and Plopper C.G. Isolation of rodent airway epithelial cell proteins facilitates in vivo proteomics studies of lung toxicity. Am. J. Physiol. Lung Cell Mol. Physiol. 286 (2004) L399-L410
107. Wheelock A.M., Boland B.C., Isbell M., Morin D., Wegesser T.C., Plopper C.G., and Buckpitt A.R. In vivo effects of ozone exposure on protein adduct formation by 1-nitronaphthalene in rat lung. Am. J. Respir. Cell Mol. Biol. 33 (2005) 130-137
108. Witschi H., Espiritu I., Maronpot R.R., Pinkerton K.E., and Jones A.D. The carcinogenic potential of the gas phase of environmental tobacco smoke. Carcinogenesis 18 (1997) 2035-2042
109. Zhang X., D'Agostino J., Wu H., Zhang Q.Y., von Weymarn L., Murphy S.E., and Ding X. CYP2A13: variable expression and role in human lung microsomal metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. J. Pharmacol. Exp. Ther. 323 (2007) 570-578